Axelyf

Hafnarfjörður, Iceland

Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.

$7.4M raised

Aug 2025

Seed

Top Investors

Brunnur VenturesOmega ehfSilfurberg

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Axelyf raised?

Axelyf has raised $7.4M in total funding. The most recent round was Seed. The last funding was announced in August 2025.

Who are Axelyf's investors?

Axelyf's investors include Brunnur Ventures, Omega ehf, Silfurberg.

Where is Axelyf headquartered?

Axelyf is headquartered in Hafnarfjörður, Iceland.

What does Axelyf do?

Axelyf is a biotechnology company that offers RNA medicines through safer and more effective lipid nanoparticle delivery.

What stage is Axelyf at?

Axelyf is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 7, 2025.

MLA

"Axelyf — Funding & Investors." VCBacked, August 7, 2025, https://www.vcbacked.co/company/axelyf. Accessed June 17, 2026.

APA

VCBacked. (2025). Axelyf — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/axelyf

Wikipedia (cite web)

{{cite web |title=Axelyf — Funding & Investors |url=https://www.vcbacked.co/company/axelyf |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 7, 2025.